期刊文献+

反义CDK4基因抑制人结肠癌细胞HT29生长 被引量:2

Antisense to CDK4 inhibits the growth of human colon cancer cells HT29
原文传递
导出
摘要 目的将反义CDK4导入人结肠癌细胞株HT29细胞,观察其对肿瘤细胞生长的影响。方法采用lipofectam ine转染方法转染HT29细胞,Northern印迹,W estern印迹,形态学和流式细胞术等方法用于转染效果的鉴定。结果转化细胞有反义CDK4的表达,而内源性CDK4 mRNA表达和蛋白合成下调,并且转化细胞的恶性行为及表型部分逆转,细胞生长受到抑制、软琼脂集落形成能力明显降低,同时揭示G1期阻滞。HT29-asCDK4细胞有较高的凋亡率。结论反义CDK4基因可抑制HT29细胞的生长和增殖、诱导其凋亡。为结直肠癌的基因治疗提供了一种新的可能的途径。 Objective Antisense CDK4 was transfected into human colorectal cancer cells HT29 to examine the effect of it on the growth and proliferation of HT29 cells. Methods Antisense CDK4 transfected the HT29 cells with lipofectamine. The transfected effects were verified by the Northern blot, Western blot, morphological method , flow cell measure, etc. Results The transformant cells showed the expression of exogenous antisense CDK4 mRNA, and downmodulation of endogenous CDK4 mRNA expression and inhibition of its protein synthesis. The transformant cells exhibited the partial reversion of the malignant phenotype and behavior, and that the cell growth and the ability of colony formation in soft agar were inhibited. The arrest of G1 phase was also revealed . the apoptosis rate is higher in HT29-asCDK4. Conclusion The antisense CDK4 gene can inhibited the cell growth and proliferation, and induce the cell apoptosis. It might provide a new way to gene therapy of the colorectal carcinoma.
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第12期846-849,共4页 National Medical Journal of China
关键词 结直肠肿瘤 细胞周期素类 细胞株 后义RNA 反义CDK4基因 Colorectal carcinoma CDK4 Cell line Antisense RNA
  • 相关文献

参考文献15

  • 1Collins K,Tyler J,Pavletich NP,et al.The cell cycle and cancer.Proc Natl Acad Sci USA,1997,94:2776-2778.
  • 2Fitzgerald MG,Harkin DP,Silva Arrieta S,et al.Prevalence of germ-line mutations in p16,p19ARF,and CDK4 in familial melanoma:analysis of a cilinic-based population.Proc nat Acad Sci,1996,93:8541-8545.
  • 3Jiang W,Zhang YJ,Kahn S,Hollstein M,et al.Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.Pro Natl Acad Sci USA,1992,90:9026-9030.
  • 4Weinstein IB and Zhou P.Cell cycle control gene defects and human cancer,In:J.R.Bertino(ed),Encyclopedia Cancer,Vol 1,pp.256-267 New York:Academic Press,1996.
  • 5Arber N,Doki Y,Han EK-H,et al.Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon.Cancer Res,1997;57:1569-1574.
  • 6Ikeda K,Monden T,Tsujie M,et al.Cyclin D,CDK4 and p16expression in colorectal cancer.Nippon Rinsho,1996,54:1054-1059
  • 7Zhang T,Nanney LB,Luongo C,et al.Concurrent overecpression of cyclin D1 and cyclin-dependent kinase 4(Cdk4) intestinal adenomas from multiple intestinal neoplasia(Min) mice and human familial adenomatous polyposis patients.Cancer Res,1997,57:169-175.
  • 8叶颖江,祝学光,王永潮,桑建利,顾晋,曲军,于永祥,王杉.人结直肠癌组织CDK4基因和蛋白表达及其临床意义[J].中华普通外科杂志,2000,15(6):370-372. 被引量:2
  • 9Soni R,O′Reilly T,Furet P,et al.Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4.J Natl Cancer Inst,2001,93:436-446.
  • 10Yu B,Lane ME,Wakler S.SU9516,a cyclin-dependent kinase 2 inhibitor,promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.Biochemical Pharm.acology,2002,64:1091-1100.

二级参考文献3

  • 1Arber N,Cancer Res,1997年,57卷,1569页
  • 2Zhang T,Cancer Res,1997年,57卷,169页
  • 3He J,Cancer Res,1994年,54卷,5804页

共引文献1

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部